{
    "2018-03-19": [
        [
            {
                "time": "2018-06-25",
                "original_text": "J&J Gets $2.1B Offer for LifeScan Diabetes Device Unit",
                "features": {
                    "keywords": [
                        "J&J",
                        "offer",
                        "LifeScan",
                        "Diabetes",
                        "Device",
                        "Unit"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-06-25",
                "original_text": "The Zacks Analyst Blog Highlights: Biogen, AbbVie, Novartis, Teva and Celgene",
                "features": {
                    "keywords": [
                        "Zacks",
                        "Analyst",
                        "Blog",
                        "Biogen",
                        "AbbVie",
                        "Novartis",
                        "Teva",
                        "Celgene"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-06-25",
                "original_text": "See what the IHS Markit Score report has to say about AbbVie Inc.",
                "features": {
                    "keywords": [
                        "IHS",
                        "Markit",
                        "Score",
                        "report",
                        "AbbVie",
                        "Inc."
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}